News Focus
News Focus
Replies to #44523 on Biotech Values
icon url

quantumdot

04/07/07 10:01 AM

#44524 RE: gofishmarko #44523

Yes, cleverly worded wasn't it?
icon url

DewDiligence

04/07/07 3:44 PM

#44536 RE: gofishmarko #44523

I thought the survey was clear enough: one answer choice that enables approval for marketing immediately or with a short delay and one answer choice that doesn’t. That’s the main issue, is it not?

>Anyone who thought (in effect : accelerated approval) was the likely outcome would probably have chosen the "approvable" option in the survey, since that was the only answer that listed completion of 02b as a condition<

It would be illogical for someone to vote wrongly in this manner because such a vote misses the basic question of whether approval for marketing is a near-term event or isn’t.

p.s. If anyone did vote wrongly because they were confused by the wording, please speak up so that we can change the tally accordingly.
icon url

AlpineBV_Miller

04/08/07 2:25 AM

#44560 RE: gofishmarko #44523

Accelerated approval is not available on a survival endpoint.